These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1297 related articles for article (PubMed ID: 10416321)

  • 1. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kala-azar in Varanasi (UP)--preliminary observations.
    Rai RN; Sehgal PN
    J Commun Dis; 1990 Jun; 22(2):120-3. PubMed ID: 2098410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A report on the indoor residual spraying (IRS) in the control of Phlebotomus argentipes, the vector of visceral leishmaniasis in Bihar (India): an initiative towards total elimination targeting 2015 (Series-1).
    Kumar V; Kesari S; Dinesh DS; Tiwari AK; Kumar AJ; Kumar R; Singh VP; Das P
    J Vector Borne Dis; 2009 Sep; 46(3):225-9. PubMed ID: 19724087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sandfly survey in Nainital and Almora districts of Uttaranchal with particular reference to Phlebotomus argentipes, vector of kala-azar.
    Rao JS; Sharma SK; Bhattacharya D; Saxena NB
    J Commun Dis; 2001 Mar; 33(1):7-11. PubMed ID: 11898464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
    Thakur CP; Kumar A; Mitra G; Thakur S; Sinha PK; Das P; Bhattacharya SK; Sinha A
    Indian J Med Res; 2008 Jul; 128(1):38-44. PubMed ID: 18820357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral leishmaniasis in Nepal during 1980-2006.
    Joshi DD; Sharma M; Bhandari S
    J Commun Dis; 2006 Mar; 38(2):139-48. PubMed ID: 17370676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kala-azar in Ballia district, Uttar Pradesh.
    Rao JS; Rahman SJ; Singh J; Singh SK
    J Commun Dis; 1992 Jun; 24(2):116-20. PubMed ID: 1344169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kala-azar elimination programme in India.
    Dhillon GP; Sharma SN; Nair B
    J Indian Med Assoc; 2008 Oct; 106(10):664, 666-8. PubMed ID: 19552101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?
    Addy M; Nandy A
    Bull World Health Organ; 1992; 70(3):341-6. PubMed ID: 1638662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kala-azar control programme for remote tribal communities.
    Thakur CP; Frances Sister ; Therese Sister ; Victoria Sister ; Puspa Sister
    World Health Forum; 1994; 15(3):245-7. PubMed ID: 7945751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicoepidemiological profile of kala azar patients in Delhi.
    Mittal V; Bhatia R; Sehgal S
    J Commun Dis; 1989 Dec; 21(4):255-61. PubMed ID: 2638373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kala-azar epidemic in Varanasi district, India.
    Kumar R; Kumar P; Chowdhary RK; Pai K; Mishra CP; Kumar K; Pandey HP; Singh VP; Sundar S
    Bull World Health Organ; 1999; 77(5):371-4. PubMed ID: 10361752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insecticide resistance in phlebotomine sandflies in Southeast Asia with emphasis on the Indian subcontinent.
    Dhiman RC; Yadav RS
    Infect Dis Poverty; 2016 Nov; 5(1):106. PubMed ID: 27817749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis (kala-azar)--the Bihar (India) perspective.
    Sinha PK; Ranjan A; Singh VP; Das VN; Pandey K; Kumar N; Verma N; Lal CS; Sur D; Manna B; Bhattacharya SK
    J Infect; 2006 Jul; 53(1):60-4. PubMed ID: 16269185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kala-azar in Uttar Pradesh--a study of 66 patients.
    Mittal V; Singh VK; Ichhpujani RL
    J Commun Dis; 2002 Mar; 34(1):43-9. PubMed ID: 12718341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new strategy for elimination of kala-azar from rural Bihar.
    Thakur CP
    Indian J Med Res; 2007 Nov; 126(5):447-51. PubMed ID: 18160749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinico-epidemiological profiles of post-kala-azar dermal leishmaniasis in Varanasi.
    Rai RN; Kumar M; Srivastava A; Joshi RD; Asthana AK; Tripathi VC; Dutta KK
    J Commun Dis; 1989 Sep; 21(3):214-7. PubMed ID: 2614049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B in resistant kala-azar in Bihar.
    Thakur CP; Sinha GP; Pandey AK; Barat D; Sinha PK
    Natl Med J India; 1993; 6(2):57-60. PubMed ID: 8477209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.